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Heterogeneous T cell receptor Vfi gene repertoire in murine interstitial
nephritis. Anti-tubular basement membrane disease (aTBM) produces T
cell-mediated interstitial nephritis in SJL/J mice following immunization
with heterologous renal tubular antigen. Initial mononuclear infiltrates
appear in vivo aftcr six to eight weeks, with subsequent progression to
renal fibrosis and endstage kidney disease. Cultured lymph node derived
nephritogenic T cells from these mice react to a small epitopic region of
the 3M- 1 target antigen and share a common amino acid motif in their V
CDR3 regions. We now have used RT-PCR to further characterize the
renal expression of T cell receptor (TcR) V/3 gene repertoires during the
course of this disease. Individual kidneys with focal mononuclear infil-
trates characteristic of early aTBM disease express up to three different
TcR V genes; however, the same V genes are not found in all kidneys
at the same early stage of injury. DNA sequencing of the V RT-PCR
products reveals a heterogeneous population of VDJ recombinations and
deduced CDR3 amino acid sequences. Our studies do not support TeR
vp region gene restriction in histologically-detectable aTBM disease, but
are more consistent with a dynamic, organ-specific autoimmune disease,
directed at multiple autoantigenie epitopes.
Analyses of T cell receptor (TeR) variable (V) region gene
repertoires have provided important information regarding the
basic pathophysiology of autoimmunity, and have resulted in
specific immunotherapeutic interventions for the treatment of
autoimmune diseases [I]. Initial studies performed in experimen-
tal allergic encephalomyelitis (EAE) showed that the TcR V
gene repertoire of autoreactive, encephalitogenic T lymphocytes
was highly restricted, and that specific anti-TcR Vu-region anti-
bodies could successfully ameliorate progressive disease [2, 3].
Confirmation of this work by others led to formulation of the
"V-region hypothesis," which suggests that a single epitope of a
single antigen results in clonal expansion of a small number of
autoreactive lymphocytes (all utilizing the same V-region), which
then cause disease [1. More recent work in both animals and
humans has demonstrated that TeR V gene repertoires in auto-
immune diseases may not be as restricted as originally anticipated
[4—101. There has been little published data, however, regarding
the TcR V-region gene repertoire in autoimmune renal disease
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[ii, 12], and those studies that have been performed have focused
on analysis of in vitro cultured T cell clones, not diseased kidneys
[11, 12].
We have been studying a model of T cell-mediated autoimmune
interstitial nephritis in mice, called anti-tubular basement mem-
brane disease (TBM disease), which is induced by immunization
with hetcrologous renal tubular antigen in complete Freund's
adjuvant (RTAICFA) [13, 14]. Initial T cell infiltration occurs
after six to eight weeks, and progresses to interstitial fibrosis,
end-stage renal disease and death within 16 to 20 weeks [13, 14].
The target antigen, 3M-i, is a 48 kDa glycoprotein found on the
basolateral surface of proximal tubular epithelial cells [15, 16].
Prior studies have revealed that a 3M-i-reactive, MHC 11-re-
stricted, CD4 helper T cell initially emerges after immunization,
but that this cell is unable to directly transfer disease [17]. Instead,
the CD4 helper cell induces a 3M-I-reactive, MHC I-restricted,
CD8 effector T cell that mediates delayed-type hypersensitivity
(DTFI), renal proximal tubular cytotoxicity, and is capable of
directly transferring disease upon adoptive transfer to naive
syngeneic animals [17—19].
Our recent interests have been focused on analysis of the TcR
V gene repertoire of nephritogenic T cells in this disease model,
in an attempt to identify potential targets for specific immuno-
therapeutic interventions. We have previously isolated and char-
acterized a panel of nephritogenic CD4 helper T cell clones from
peripheral lymph nodes of animals immunized to get aTBM
disease [12]. These T cell clones all recognize a single 14 residue
immunodominant epitope contained within the target antigen,
3M-l [121. Analysis of TeR V gene usage by these clones
revealed the presence of multiple V genes, with some preferen-
tial use of V1314, and evidence of common amino acid sequences
across the putative CDR3 regions [12]. In order to extend these in
vitro findings to a well-characterized in vivo model system, and to
evaluate the TcR V13 gene repertoire within the diseased organs
themselves, we have undertaken a semiquantitative reverse tran-
scription polymerase chain reaction (RT-PCR) analysis of the
TcR V[3 gene repertoire throughout the course of anti-TBM
disease.
Methods
Antigens
Rabbit renal tubular antigen (RTA) was isolated by previously
published methods, and emulsified at 4 mglml with complete
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Freund's adjuvant (2 mg/mi of purified protein derivative from
Connaught Laboratories Ltd, Toronto, Ontario, Canada mixed
with incomplete Freund's adjuvant purchased from Gibco BRL,
Grand Island, NY, USA) to produce RTAJCFA.
Immunization
SJL mice (H2s) four to six weeks of age (Jackson Laboratory,
Bar Harbor, ME, USA) were immunized with RTA/CFA in
multiple sites to get aTBM disease. Some animals were immu-
nized with CFA alone as controls.
Antibodies
Fluorescein (FITC)-conjugated and phycoerytherin (PE)-con-
jugated antibodies to murine CD3 [20], TcR V132 [21], TcR VJ34
[21, 22], TcR Vj36 [21, 23], TcR Vf37 [21, 24], and TcR V1314 [25]
were purchased from Pharmingen (San Diego, CA, USA). FITC-
conjugated anti-TcR Vp8.1, 8.2 [26] was a kind gift of F. Heinzel
(Dept. of Medicine, Cleveland VA Med Center, Cleveland, OH,
USA).
Fluorescent activated cell sorter analysis (FACS) of
peripheral lymphocytes
Pooled single cell suspensions of whole spleens were made after
pushing each organ through a 60 mesh metal screen, and washing
with DMEM/10% fetal bovine serum (Sigma, St. Louis, MO,
USA). Enrichment for lymphocytes was performed by running the
cell suspensions through Lympholyte-M (Cedar Lane Laborato-
ries, Ltd., Hornsby, Ontario, Canada), as per the manufacturer's
recommendations. One to 2 x 106 cells were incubated with a
1:100 dilution of labeled antibody in 50A of PBS/0.1% BSA for 30
minutes on ice. The cells were washed three times with phosphate
buffer saline (PBS) 0.1% BSA, suspended in 1 ml of freshly made
1% paraformaldehyde, and stored covered in foil at 4°C. FACS
analysis was performed on a Becton/Dickinson flow cytometer
and analyzed with C30 software.
Organ harvest
At various time points after immunization, the animals were
sacrificed, and the organs perfused with 30 milliliters of phosphate
buffer saline (PBS) via intracardiac puncture, to eliminate periph-
eral blood contamination. Each kidney was divided in half: one
portion was snap frozen and used for polymerase chain reaction
(PCR) analysis of V3 genes, while the other portion was placed in
formalin for histologic analysis. Slides were prepared and stained
with hematoxylin and eosin by standard methods. Each slide was
evaluated by a blinded investigator for the extent of disease
involvement using the following scoring method: 0, no disease;
0.5, focal areas of lymphocytic infiltrates; 1, lymphocytic infiltrates
in less than 10% of the renal cortex; 2, lymphocytic infiltrates in
less than 25% of the renal cortex; 3, lymphocytic infiltrates
comprising 50 to 75% of the renal cortex; 4, extensive infiltrates of
greater than 75% of the renal cortex with tubular atrophy and
scarring [17]. The spleen from each animal was also harvested and
frozen for use in PCR experiments.
Polymerase chain reaction (RT-PCR) for TcR VP genes
Total RNA was prepared from snap frozen kidney or spleen
tissue using RNAstat (Tel-Test Inc., Friendswood, TX, USA) as
per manufacturer's recommendations. Oligo dT-primed first
strand synthesis was performed with MMLV reverse transcriptase
[27]. PCR was performed in 100A total volume containing 1OA of
10>< buffer (Perkin-Elmer Cetus, Exton, PA, USA), 200 jsM
dGTP, dCTP, dATP, dTTP, 0.25 A Taq polymerase (Perkin-Elmer
Cetus), 1 js of RNA/cDNA template, 40 pmol of 3' CJ3 antisense
primer PH12 (5'CTCAAACAAGGAGACCTFG3') and 40 pmol
of 5' sense V3 region primer. The 5' V3 amplification primers for
Vpl-Vp19 were derived by William Smoyer and Carolyn Kelly
(University of Pennsylvania, Philadelphia, PA, and University of
Calfornia San Diego, San Diego, CA, USA) using a matrix
analysis (MacVector sequence analysis software for the Macin-
tosh, IBI, New Haven, CT, USA) and the murine V gene
sequences (manuscript in preparation). Each primer is a 20 mer
designed to have minimal cross-reactivity to all other V3 region
genes and encodes a product of unique predicted size. The V20
primer was designed later from the published sequence using the
same criteria, and has the following sequence: 5'GCAGTTACA-
CAGAAGCCAAG3'. Predicted sizes for PCR products using the
3' PH12 primer and each of the 5' V primers are as follows:
V/31—387 bp, Vp2—256 bp, V133—250 bp, V134—213 bp, V/36—373
bp, Vp7—165 bp, VJ310—355 bp, V/314—253 bp, Vp15—394 bp,
Vf316—234 bp, Vp17—319 bp, Vf318—327 bp, Vp19—312 bp, and
Vl320—376 bp. The actual sizes of each product vary by several
base pairs secondary to N region additions and deletions. A
master mix of all reagents except the 5' primers was made and
divided into 14 tubes each containing one specific V region
primer. A fifteenth control tube was run containing two constant
region primers, 5 '-C3 (5 'TACCCTrGTGTGCTTGGCCA3')
and WS-2 (5'GAACTGCACYI'GGCAGC-GGA3'), encoding a
predicted product of 207 bp. Amplifications were performed in a
DNA thermal cycler (Perkin-Elmer Cetus) for 32 to 38 cycles at
92° denature for 60 seconds, 54° anneal for 60 seconds, and 72°
elongation for 120 seconds.
Southern blots analysis of RT-PCR reactions
Fifteen percent of each RT-PCR product was run on a 1.2%
agarose gel and transferred to a Magna NT nylon membrane
(Fisher Scientific, Pittsburgh, PA, USA) with a Posiblot positive
pressure blotting system (Stratagene, La Jolla, CA, USA) as per
the manufacturer's recommendations. The blots were then dena-
tured for 10 minutes with 0.4 M NaOH, washed in 2 X SSC and
UV cross-linked (Stratalinker, Stratagene).
Four micrograms of a common internal C/3 oligonucleotide,
Cint, (5'GAGTCACATTTCTCAGATC3'), were end-labeled
using 1 unit of polynucleotide kinase (Promega, Madison, WI,
USA) 2A of lox buffer, and 3A of 32P-yATP (Amersham,
Arlington Hts, IL, USA) in a 20A volume for 45 minutes at 37°C.
The labeled probe was separated from unincorporated nucleo-
tides using a G25 spin column (Boerhinger Manheim, Indianap-
olis, IN, USA), as per the manufacturer's recommendations.
Prehybridization was performed in 6 x SSC, 50 ifiM disodium
phosphate pH 6.7, 5x Denhardt's solution, 0.1 mg/ml boiled
salmon sperm DNA at 37°C for a minimum of three hours.
Hybridizations were performed in 6 X SSC, 50 ma disodium
phosphate pH 6.7, 5 x Denhardt's solution, 0.1 mg/ml boiled
salmon sperm DNA, 100 mg/ml dextran sulfate at 37°C with 6 x
l0—1 x 106 counts per milliliter of labeled probe, overnight. The
blots were washed twice in 6 x SSC at 4°C for 30 minutes, then
twice at 55°C for 20 minutes in 3 M TMAC, 50 mM Tris HC1 pH
8.0, 2 mrvi EDTA, and 0.1% SDS. The blots were analyzed on a
A32 cycles
35 cycles
38 cycles
—250 bp
—250 bp
—250 bp4_
co
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BioRad GS-250 Molecular Imager (BioRad Laboratories, Her-
cules, CA, USA) using PhosphorAnalyst software (BioRad Lab-
oratories) for the Macintosh. After subtraction of the background,
the density of each band was determined, and was expressed as a
percentage of the total of all of the V regions for that organ.
Statistical comparisons were performed using the Student's t-test.
Some blots were additionally exposed to film and photographed.
Cloning and sequencing of Vj3 RT-PCR products
Equal aliquots of each of the 14 indivdual V RT-PCR
products from selected diseased kidneys were mixed together, and
shotgun cloned into the pCR 3000 TA cloning vector (In vitrogen,
La Jolla, CA, USA) as previously described [28]. DNA plasmid
preparations were performed on individual colonies using the
Magic Miniprep kit (Promega), as per the manufacturer's recom-
mendations. DNA sequencing was performed in both directions
by the dideoxy chain determination method using fluorescein
labeled primers as described by the manufacter (Pharmacia,
Uppsala, Sweden), and run on a Pharmacia LKB A.L.F. Auto-
mated Sequencing apparatus. Sequence analysis was done using
the MacVector sequence analysis program for the Macintosh
(IBI, New Haven, CT, USA).
Statistical analysis
Statistical comparisons were done using the Student's t-test.
Results
Optimization of the RT-PCR technique
Initial studies were performed to determine optimal parameters
for amplification of each V PCR product. Figure 1 shows a
representative experiment analyzing the effect of PCR cycle
number on the peripheral V gene distribution using 1 jig of
splenic cDNA/RNA. Note that all of the PCR products are of
predicted size, and bind to the internal primer (Fig. 1A). Vf3 genes
deleted in SJL mice [29] were not detected by RT-PCR (data not
shown). The relative density of each detected band, as quantified
using a molecular phosphorimager, is graphically depicted in
Figure lB. The signal intensity for each V gene PCR product
increases over the 32 to 38 cycle range, with the exception of V/32,
which reaches a plateau after 35 cycles. Additionally, the relative
percentage of each V PCR product, expressed as a fraction of all
of the V products for that organ, is essentially identical at 32 and
35 amplification cycles (data not shown). We therefore performed
all subsequent experiments with 1 jig of RT product per reaction,
92°C for one minute, 54°C for one minute, and 72°C for two
minutes, for 35 amplification cycles.
Analysis of the peripheral TcR V gene repertoire in
nonimmunized mice
To define the baseline peripheral TcR V gene repertoire, we
performed RT-PCR for TcR V genes with splenic RNA isolated
from multiple control (nonimmunized) animals (Fig. 2). Figure
B
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Fig. 1. Effect of amplification cycle number on T
cell receptor V/3 RT-PCR products. A. Southern
blots of V3 RT-PCR products from splenic
RNA, probed with internal oligonucleotide
Cpint, for 32, 35 and 38 cycles. B.
Quantification of the individual bands from A,
using the Bin Rad GS-250 Molecular Imager.
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Analysis of the peripheral V/3 gene repertoire in
immunized animals
We next wished to evaluate whether immunization producing
aTBM disease, or immunization with adjuvant alone, affects the
peripheral V13 gene repertoire. Splenic TcR VP gene expression 8
to 10 weeks after immunization with CFA alone, and after
immunization with RTA/CFA to get sTBM disease is shown in
Figure 4, and demonstrates no significant differences between the
two groups (P > 0.05). Additionally, there are no significant
differences (P> 0.05) between the peripheral V gene repertoire
of nonimmunized animals (Fig. 2B) and animals immunized with
CFA alone or animals immunized with RTAJCFA to get disease
(Fig. 4).
TcR Vj3 gene distribution in diseased kidneys
Fig. 2. Penpheral T cell receptor V13 gene repertoire in unimmunized mice.
A. Representative Southern blot of TcR V13 RT-PCR products from
splenic RNA of an unimmunized animal. B. Relative quantity of each
individual V RT-PCR product expressed as a percentage of the total of
all VJ3 genes combined (N = 4).
2A shows a representative autoradiograph of the peripheral TcR
vp gene repertoire from a normal animal, while Figure 2B
graphically depicts the cumulative results of multiple experiments
(N 4), and shows the relative expression of each vpgene family
as a percentage of the total of all V genes combined. SJL mice
have a genomic deletion of a portion of the TcR V3 genes and
thus do not express Vp5, 8, 9, 11, 12, or 13 29]. Spleens from
unimmunized control animals contain transcripts for all nonde-
leted V genes, with Vp2, 4, 6 and 17 comprising the highest
individual percentages, while V/310, 15, 18, 19, 20 are present in
significantly lower levels (Fig. 2B). This splenic TcR V gene
repertoire did not change over the 20-week time period that
animals were maintained in our animal facility (data not shown).
Additionally, we studied multiple different shipments of mice,
both male and female, born over an 18 months period, with
similar findings (data not shown).
Using commercially available antibodies specific for individual
TcR VP gene families (Pharmingen), we next studied selected V
gene product expression on the surface of peripheral splenic
lymphocytes. Figure 3 depicts a panel of two color FACS analyses
evaluating the percentage of CD3 + splenic lymphocytes that
additionally express Vf32, 4, 6, 7, 8 and 14. Based on pooled
lymphocytes from three individual spleens, 13.5% of CD3+
splenic cells express Vf32, 13.9% express Vp4, 10.7% express VJ36,
10.5% express V/37, and 7.1% express Vp14. V/38 was not
detected, as expected from the known genomic deletion of this
element in SJL/J mice [29J. These numbers are similar to the
distribution determined by PCR analysis (Fig. 2B), where V132, 4,
6,7, and 14 comprise 11.0%, 11.3%, 11.0%, 8.8%, and 6.5% of the
total VP genes, respectively.
To minimize background blood contamination, each kidney was
perfused with 30 ml of PBS via cardiac puncture, prior to harvest.
This procedure routinely resulted in a visible blanching of the
kidney, with no detectable blood in routine histologic sections.
Figure 5 shows a photomicrograph of a normal kidney from an
unimmunized animal, with an accompanying Southern blot of the
RT-PCR for TcR V genes. As expected, there is minimal
detectable TcR mRNA present in this normal organ, as compared
to the splenic tissue. The strongest signals are VJ32 and V136, some
of the same V genes that are expressed in the highest levels in
the periphery (Fig. 2), and presumably reflect residual blood
contamination and the high sensitivity of the RT-PCR technique.
TcR VP region gene analysis of histologically normal kidneys
from animals immunized with adjuvant alone revealed similar
findings (results not shown).
In contrast, kidneys with histologic grade 0.5 to 1 disease (focal
mononuclear infiltrates in less than 10% of the renal cortex; Fig.
6A), predominantly express strong signals for up to three TcR vp
PCR products (Fig. 6B), with the remaining signals being compa-
rable to the background levels found in the histologically normal
kidneys. Vp2, 6, and 7 are found in many of the kidneys with
vTBM disease, but other V region PCR products (3, 14 and 16)
are present as well. No single V gene family is expressed
preferentially in all kidneys. TcR V PCR products were not
detectable above background in kidneys of animals immunized
with RTA!CFA, prior to the histological detection of disease
(data not shown).
Figure 7 shows the TcR vp gene repertoire in kidneys with
advanced aTBM disease. A diseased kidney with typical grade 3
to 4 histology is shown in Figure 7A, and reveals a marked
interstitial infiltrate with peritubular edema and early fibrosis. The
TcR V3 genes found in 5 different kidneys with grade 3 to 4
histology are shown in Figure 7B, and reveals prominent expres-
sion of up to 10 different V gene products in any individual
organ, with no discernible reproducible pattern of expression of
any single V gene family. Notably, all of the organs were
perfused with PBS prior to isolation of the RNA in order to
minimize peripheral T cell contamination of the RT-PCR prod-
ucts. As can be seen, each of the TcR V3 gene distributions in
Figure 7 differ from that found in the spleen (Fig. 2A), with some
TcR V genes being totally absent, thus eliminating the possibility
that the increased heterogeneity can be simply attributed to
contaminating peripheral blood.
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Fig. 4. Peripheral T cell receptor V/3 gene repertoire from immunized
animals. Relative quantity of splenic Vf3 RT-PCR products expressed as a
percentage of the total of all V/3 genes combined. Black bars, animals
immunized with CFA alone (N = 4);striped bars, animals immunized with
RTAICFA (N = 7). There are no statistically significant differences
between groups, and no statistically significant differences between either
group and the unimmunized animals (Fig. 2).
Sequence analysis of V/3 gene products in early csTBM disease
To analyze the f3 chain CDR3 sequences across the VDJ
junctions of the TcRs from the diseased organs, we next subcloned
and sequenced individual RT-PCR products from two kidneys
with histologically focal (early) aTBM disease. For each kidney,
two separate reverse transcription reactions, and four separate
PCR reactions were used to generate the eDNA products used in
the sequencing reactions. The deduced amino acid sequences are
1 2 3 4 6 7 1014151617181920
Fig. 5. T cell receptor 17/3 RT-PCR products in normal renal tissue. A.
Photomicrograph of normal kidney from an unimmunized mouse stained
with hematoxylin and eosin (magnification 40X). B. Representative
Southern blot of RT-PCR for V/3 genes using RNA from a normal kidney.
shown in Table 1. For each sequence, the open reading frame
confirms the presence of a known V/3 and J/3 gene. In both of the
kidneys analyzed, there is a predominance of Vf37 and V/33,
although other V13 genes are present as well. The sequences from
both organs also show some evidence for clonal expansion of
individual T cell clones, in that several sequences were isolated
from multiple different colonies, derived from different PCR
reactions (Table 1). Several of the repeatedly isolated sequences
from both organs contained V133 and an n region encoded Arg
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Fig. 3. TcR V13 gene product expression by
peripheral lymphocytes. FACS analysis of splenic
lymphocytes from unimmunized animals using
PE-conjugated anti-CD3 (Y axis) and individual
FITC-conjugated anti-V/3 region antibodies (X
axis). Splenocytes were pooled from three
individual animals. The percentage of CD3 + T
cells also expressing V/32, 4, 6, 7, 8, and 14 is
13.5%, 13.9%, 10.7%, 10.5%, 0%, and 7.1%,
respectively.
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Fig. 6. T cell receptor Vf3 RT-PCR products in
early aTBM disease. A. Focal area of
mononuclear cell infiltrate adjacent to
histologically normal renal tissue in a kidney
with grade I aTBM disease, stained with
hematoxylin and eosin (magnification 40x). B.
Southern blot of V13 RT-PCR products from 5
individual kidneys affected with histologic grade
0.5 to 1 aTBM disease.
Fig. 7. T cell receptor V13 RT-PCR products in
extensive aTBM disease. A. Extensive
mononuclear cell infiltrate with tubular
destruction and peritubular edema in a kidney
with grade 3 uTBM disease. B. Southern blot of
V13 RT-PCR products from 5 individual kidneys
affected with histologic grade 3 to 4 oTBM
disease.
residue. In fact, there is an overrepresentation of Arg residues
encoded by n region additions/deletions in the sequences from
both kidneys (Table 1). Interestingly, a similar n region encoded
Arg (or structually similar Lys or His residue) was found in many
of the CDR3J3 chain sequences from our CD4+ nephritogenic T
cell clones [121. On the other hand, there is remarkable hetero-
geneity in both the length of the CDR3 regions as well as in the
individual residues found within the regions. These findings hold
true even among those sequences cloned from the same organ,
and sharing the same V13 and J1 genes.
Discussion
Initial studies of T cell receptor Vj3 gene expression in EAE [2,
3, 30], collagen arthritis [31, 32], and several other autoimmune
disease models [reviewed in 33] suggested that autoreactive T cell
repertoires are highly restricted. Based on such findings, many
investigators hypothesized that autoimmunity was mediated by
clonal expansion of a limited number of autoreactive T cells that
recognize a single (or a few) determinant(s) derived from an
autoantigenic protein [1, 4]. In fact, DNA sequencing of TcR 13
chains from encephalitogenic T cell clones later revealed a
recurrent amino acid residue motif across the CDR3 regions [34],
further suggesting that autoimmune responses could be uniquely
directed at a small number of epitopes. Other studies in EAE [5,
7], however, as well as analyses of NOD mice with diabetes [10]
and thyroiditis [91 have revealed a more heterogeneous T cell
receptor V13 gene repertoire. Additionally, studies of T cell
receptor V region genes used in human autoimmune disease have
yielded mixed findings; some cases of biased expression of TcRs
have been noted [33, 35, 361, while others experiments suggest a
more diverse repertoire [33, 37, 38].
Our studies are the first to comprehensively analyze the in vivo
TcR Vp gene repertoire in any model of autoimmune renal
disease. The results described herein reveal that the T cell
receptors detected in kidneys affected by csTBM disease are quite
diverse, and suggest a polyclonal response. Although private
repertoires of restricted TcR V13 gene families (containing up to
three different V13 genes) are detectable in individual organs with
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Table 1. TcR CDR3f3 sequences from kidneys with focal T cell infiltrates
A. Kidney 1 B. Kidney 2
CDR3 V13/J13 CDR3 V13/J13
CTCSA P SYNSPLYFAAGTRL 2/1.6 CTCS ADLGG AETLYFGSGTRL 2/2.3
CASS LSGGL NYAEQFFGPGTRL 6/2.1
CASS QTGGAL AEQFFGPGTRL 4/2.1 CASS
CASS
QETGGAL AEQFFGPGTRL
QEYN NYAEQFFGPGTRL
4/2.1
4/2.1 (2 colonies)a
CASS RDRG DTQYFGPGTRL 3/2.5(4 colonies)a CASS QDK DTQYFGPGTRL 4/2.5
CASS LSR RD SDYTFGSGTRL 3/1.2
CAS RGQG YAEGFFGPGTRL 3/2.1 CASA IRDRG SDTQYFGPGTRL
— —
6/2.5
CASS ARGF NSPLYFAAGTRL 3/1.6
CASS QGVN ERLFFGHGTKL 3/1.4(2 colonies)a CAS RWYT GQLYFGEGSKL 3/2.2(3 colonies)a
CASS IQGGQ NTLYFGAGTRL 3/2.4(2 colonies)a CASS RQGNNQAQH FGEGTRL 3/1.5
CASS LAy NQDTQYFGPGTRL 3/2.5 CASSL SR NYAEQFFGPGTRL 3/2.1 (2 colonies)'
CASS
CASS
RQEAF GNTNYFGEGSRL
PGLG YAEQFFGPGTRL
3/1.3
7/2.1
CASS
CASS
CASS
CASSL
AGA NSDYTFGSGTRL
LKF SNERLFFGHGTKL
LTGG NTLYFGAGTRL
TGS SPLYFAAGTRL
3/1.2
3/1.4
3/2.4
3/1.6
CA QSI QNTLYFGAGTRL 7/2.4 CASS DN SYEQYFGPGTRL 3/2.6
CASS LYI NTLYFGAGTRL 7/2.4
CAS GYNQAQH FGEGTRL 7/1.5 CASS PNRGRD AEQFFGPGTRL 7/2.1
CASS RQGI TEVFFGKGTRL 7/1.1 CASS LYRGI SNERLFFGHGTKL 7/1.4
CASS ATF - YAEQFFGPGTRL 7/2.1 CASS GLGS NQDTQYFGPGTRL 7/2.5
CASS LSGTK NQDTQYFGPGTRL 7/2.5 CASS LSR RG TGQTYFGEGSKL 7/2.2
CASS LLI SAETLYFGSGTRL 7/2.3 CASS LEGASA ETLYFGSGTRL 7/2.3(2 colonies)a
Standard single letter codes for amino acids are employed. Underlined residues are encoded by n region additions or deletions. Bold residues are
positively charged arginine (R), histine (H), or lysine (K) residues encoded within the putative CDR3 regions.
a Multiple individual colonies contained identical sequences encoding these CDR3 regions
focal disease, and there is some evidence for clonal expansion of
individual T cells, there is not an assured pattern of V/3 expression
in all organs tested. The heterogeneity of CDR3/3 sequences,
despite the presence of shared V/3 and/or J13genes, confirms the
polyclonal nature of the response. Moreover, further diversity is
manifested as the disease progresses, as indicated by the increased
numbers of detectable Vf3 genes by RT-PCR in kidneys with
histologically more advanced lesions.
All of these findings must be interpreted in the context of
known information about disease relevant autoantigens. Several
published studies have noted that T cells expressing structurally
distinct TcRs are capable of recognizing the same peptide/MHC
complex [8, 10, 12, 38]. Previous work by our group has estab-
lished that the autoreactive T cell and B cell repertoires in aTBM
disease are highly focused towards a single immundominant
region of the 3M-i target antigen [12, 15, 39, 40]. We have shown
that a panel of nephritogenic CD4+ T cell clones, expressing a
variety of TcR V genes (including V/314, V133 and V/37), all
recognize P3 (expressed in the context of IAs), a peptide derived
from 3M-i [12]. Interestingly, these T cell clones expressed TcRs
containing positively charged CDR3/3 regions, with an over-
representation of Arg, Lys, or His residues encoded by n region
additions or deletions [12]. Many of the TcR sequences derived
from our diseased kidneys express V3 and Vp7, and also contain
similar positively charged residues encoded by n region additions
or deletions. These structural similarities suggest that some of the
TcR sequences obtained from diseased kidneys could be derived
from T cells reactive to P3.
Alternatively, the heterogeneous TcR repertoire could reflect T
cells reactive to a number of antigenic epitopes. Other data from
studies in EAE implicate a second autoantigen, proteolipid
protein (PLP), in addition to myelin basic protein, as an important
target of the encephalitogenic autoimmune response [41, 421. The
description of autoreactive, pathogenic T cells recognizing multi-
ple antigens, and several epitopes derived from each antigen,
provides a reasonable explanation for the detection of a hetero-
geneous TcR V repertoire during active disease [41, 42]. In an
analogous fashion, while P3 is an immundominant determinant in
the development of aTBM disease [12], it remains possible that
the renal expression of a diverse TcR V gene repertoire may
reflect an immune response directed at other 3M-i-derived
epitopes as well.
Progressively increasing heterogeneity of T cell receptor reper-
toires is also consistent with the recently described phenomenon
of epitope spreading in autoimmunity [43, 44]. Epitope spreading
is characterized by an initial autoreactive T cell response that is
focused to a single (or a few) epitope(s), and that utilizes a
restricted TcR V gene repertoire [43, 44]. The focused inflamma-
tory reaction then leads to exposure of new antigenic epitopes,
with up-regulation of costimulatory and chemoattractant mole-
cules, eventually resulting in the influx of numerous T lympho-
cytes with specificities differing from the original disease-produc-
ing cells. This heterogeneous, newly infiltrating T cell population
therefore expresses an expanded repertoire of TcR V genes [43,
44]. Our data suggest that the initial lymph node derived autoim-
mune response in csTBM disease is focused towards P3 [12], and
in individual animals, is initially biased towards selected V
regions. As the disease progresses, the heterogeneity increases,
consistent with the recruitment of T cells directed at additional
antigens. Importantly, both intramolecular and intermolecular
epitope spreading in murine EAE are prominently detectable at
two to three weeks after immunization. Since crTBM disease
requires six to eight weeks to manifest itself histologically, it is
conceivable that the autoreactive T cell response has spread to
multiple autoantigenic epitopes by that time point.
The diversity of the T cell receptor repertoire may be partially
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attributable to the fact that both CD4+ and CD8+ T cells are
necessary for the phenotypic expression of aTBM disease, and
that both T cell subtypes have been identified in the renal
infiltrates [14]. Although it remains possible that the T cell
receptor repertoire of the CD4+ or CD8+ subpopulations de-
rived from renal infiltrates may be more restricted, our previously
published findings of T cell receptor Vp gene heterogeneity in
CD4+, nephritogenic T cell clones argues that heterogeneity
exists in at least the CD4+ subpopulation as well [28].
It is also possible that some of the increased heterogeneity of
the TcR repertoire in severely diseased kidneys reflects recruit-
ment of bystander lymphocytes attracted by nonspecific mediators
of inflammation. Several studies in EAE have demonstrated the
presence of nonspecific T cells in the brains or spinal cords of
symptomatic animals [45—471, but the role played by nonspecific
polyclonal infiltrates in autoimmune renal disease is unknown.
Importantly, we have defined the renal T cell receptor V/3 gene
repertoire based on the detection of RT-PCR products, and we
cannot be certain that this truly reflects TcR protein expression on
the surface of T cells infiltrating diseased renal tissue. However,
the similarity between TcR V13 gene product expression by FACS
and TcR V13 transcript level by RT-PCR (Figs. 2 and 3), suggests
that RT-PCR can provide a reasonable approximation of the TcR
V gene product repertoire in vivo.
These studies additionally define the baseline peripheral TcR
Vf3 gene repertoire in SJL/J mice within the constraints of the 20
known VJ3 gene families, and allow for a comparison with the
peripheral repertoire from diseased animals. The similarity be-
tween TcR V/3 gene product expression by FACS and TcR VP
transcript level by RT-PCR, suggests that RT-PCR can provide a
reasonable approximation of the TcR V gene repertoire in vivo.
Our findings are additionally consistent with the relative expres-
sion of V3 genes detected by other investigators [29, 48]. Inter-
estingly, the peripheral distribution of TcR VP genes varies
minimally between unimmunized animals, does not change over
the 20 weeks during which the animals were maintained in our
animal facility, and is not affected by immunization with adjuvant
alone. Additionally, immunization with RTA'CFA has little effect
on the relative expression of peripheral TcR V/3 genes, even when
the disease is present histologically in the kidney. It remains likely,
however, that clonal expansion of individual T cells does occur
peripherally in response to immunization with RTA/CFA, but
that such expansion does not affect the overall T cell receptor
repertoire of the animal.
In conclusion, these studies, in conjunction with those from our
previously described, nephritogenic T cell clones [121, do not
support a strict "V-region hypothesis" of T cell responses in
murine aTBM disease, and suggest that restricted T cell reper-
toires are not a generalizable phenomenon of all autoimmune
diseases. T cells detected in diseased organs affected with aTBM
disease express heterogeneous T cell receptors, most consistent
with a polyclonal response directed at multiple antigenic epitopes.
The diversity of TcR V genes expressed in diseased kidneys,
even in the early stages of disease, suggests that immunotherapy
directed at individual V gene elements would not be efficacious
in the prevention or treatment of this disease. Theoretically, even
successful elimination of a single V gene family, using a specific
anti-Vregion antibody, would leave a residual autoreactive T cell
population capable of producing renal injury. Immunotherapeutic
approaches targeting immunodominant epitopes [49], or targeting
common structural characteristics of the autoreactive TcRs within
complementarily determining regions [50], may be more appro-
priate alternatives for the treatment of this disease entity.
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